A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
Clinical trial NCT07161258 · RECRUITING
Trial details
- NCT number
- NCT07161258
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-06
- Primary completion
- 2027-06-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.